Across TCGA pan-cancer cohorts, SNRPEP7 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNRPEP7’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SNRPEP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPEP7 is over-expressed in tumor.
KIRC, LIHC, and STAD are the cancer types where SNRPEP7 tumor–normal differential expression is most reproducible.